European Cancer Congress 2015.

ABSTRACT: The European Cancer Congress, which attracts a range of European cancer groups, reflected intense interest in immunotherapies. we review key sessions, including three on the anti-programmed death-1 agent nivolumab, each in a different disease setting.

SUBMITTER: Alexander W 

PROVIDER: S-EPMC4634349 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature